To view other meetings from ZAG1 choose calendar year:
| Study Section | Panel Name | Meeting Rosters |
|---|---|---|
| ZAG1 ZIJ-U(O4) | LYSOSOMES AND ALZHEIMER’S | 05/13/21 |
| ZAG1 ZIJ-R(O2) | RECRUITMENT AND RETENTION FOR ALZHEIMER'S DISEASE DIVERSITY GENETIC COHORTS IN THE ADSP (READD-ADSP) | 05/13/21 |
| ZAG1 ZIJ-R(O1) | RESEARCH INFRASTRUCTURE DEVELOPMENT FOR INTERDISCIPLINARY AGING STUDIES | 05/06/21 |
| ZAG1 ZIJ-4(M5) | 05/05/21 | |
| ZAG1 ZIJ-U(O3) | HEARING LOSS AND AGING | 05/04/21 |
| ZAG1 ZIJ-P(O1) | AD DATA | 04/30/21 |
| ZAG1 ZIJ-R(O3) | NIA ALZHEIMER'S DISEASE FAMILY-BASED | 04/28/21 |
| ZAG1 ZIJ-P(O2) | BONE-MUSCLE SIGNALING | 04/28/21 |
| ZAG1 -(A1) | NIA ALZHEIMER'S DISEASE FAMILY-BASED STUDY (NIA-AD FBS) | 04/28/21 |
| ZAG1 ZIJ-G(O1) | COVID-19 CLINICAL TRIALS | 04/23/21 |
| ZAG1 ZIJ-3(M2) | NIAC1 ZAG1-ZIJ-3-M2 | 03/25/21 |
| ZAG1 ZIJ-D(M3) | PROGRAM PROJECT | 03/16/21 |
| ZAG1 ZIJ-8(M1) | MOLECULAR DETERMINANTS OF AD RISK | 03/16/21 |
| ZAG1 ZIJ-3(M1) | GEMSSTAR | 03/15/21 |
| ZAG1 ZIJ-8(M4) | AGING ADULT BRAIN CONNECTOME | 03/15/21 |
| ZAG1 ZIJ-4(M1) | ARTIFICIAL INTELLIGENCE, TECHNOLOGY, AND AGING | 03/12/21 |
| ZAG1 ZIJ-P(M1) | AD MODEL | 03/09/21 |
| ZAG1 ZIJ-8(M2) | GUT MICROBIOMES IN BRAIN DISEASES | 03/05/21 |
| ZAG1 ZIJ-G(C1) | AGE-RELATED TRAITS IN SARDINIA5 | 03/05/21 |
| ZAG1 ZIJ-4(M3) | HEALTHSPAN AND LIFESPAN IN AGING | 03/04/21 |
| ZAG1 -(M2) | TRAUMA EXPOSURE AND COGNITIVE DECLINE IN BRAIN AGING | 03/03/21 |
| ZAG1 ZIJ-9(M2) | MOBILIZING HEALTH SYSTEMS TO SOCIOECONOMIC DIFFERENCES IN AGING (PI: JARROD DALTON) | 03/02/21 |
| ZAG1 ZIJ-G(M1) | AD CENTERS' REVIEW | 03/01/21 |
| ZAG1 ZIJ-G(M3) | RADX CLINICAL TRAILS | 02/26/21 |
| ZAG1 ZIJ-G(M2) | MULTISITE CLINICAL TRIAL EVALUATION FOR INTERVENTIONS IN OLDER INDIVIDUALS | 02/26/21 |
| ZAG1 ZIJ-D(M2) | DIVERSITY IN AGING | 02/26/21 |
| ZAG1 ZIJ-U(M2) | PEPPER CENTER MAY 2021 COUNCIL | 02/26/21 |
| ZAG1 ZIJ-9(M1) | AGING STUDIES RESEARCH INFRASTRUCTURE DEVELOPMENT R21/R33 | 02/25/21 |
| ZAG1 ZIJ-D(M4) | CONFERENCE GRANTS | 02/25/21 |
| ZAG1 ZIJ-6(M3) | DRUG REPOSITIONING AND COMBINATION THERAPY FOR AD | 02/23/21 |
| ZAG1 ZIJ-4(M2) | TECHNOLOGY ENGAGEMENT AND AGING | 02/19/21 |
| ZAG1 ZIJ-U(M3) | DIABETES AND AGING | 02/18/21 |
| ZAG1 ZIJ-5(M1) | AGING AND BALANCE | 02/18/21 |
| ZAG1 ZIJ-1(M1) | PRECLINICAL DEVELOPMENT OF AGING THERAPEUTICS | 02/18/21 |
| ZAG1 ZIJ-D(M1) | TRANSITION TO AGING | 02/17/21 |
| ZAG1 ZIJ-8(M3) | USING THE SCIENCE OF SCIENCE TO DOCUMENT AND ACCELERATE PROGRESS IN TREATING ALZHEIMER'S DISEASE | 02/12/21 |
| ZAG1 ZIJ-6(M1) | NEURAL NETWORK DYSFUNCTION IN AD | 02/02/21 |
| ZAG1 ZIJ-6(M4) | ALZHEIMER’S DISEASE DRUG DEVELOPMENT | 01/22/21 |
| ZAG1 -(M1) | APOE AND ALZHEIMER’S DISEASE | 01/22/21 |
| ZAG1 ZIJ-P(M3) | OXIDATIVE STRESS | 01/19/21 |
| ZAG1 ZIJ-2(M1) | FRAILTY AND CANCER | 01/15/21 |
| ZAG1 ZIJ-U(M1) | DIET AND AGING | 01/15/21 |
| ZAG1 ZIJ-6(M2) | NETWORK OF OLDER PERSONS WITH SUPERIOR COGNITION PERFORMANCE | 01/14/21 |
| ZAG1 ZIJ-1(M2) | EARLY AD PATHOLOGICAL MECHANISMS | 01/08/21 |
| ZAG1 ZIJ-2(M2) | MICROBIOME AND AGING 1 | 01/07/21 |